레지오넬라 검사 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 최종 용도별(미생물 배양, 직접 형광 항체 염색, PCR, 기타), 지역별, 경쟁별(2020-2030년)
Legionella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End Use (Microbial culture, Direct fluorescent antibody stain, PCR, Others), By Region & Competition, 2020-2030F
상품코드:1692368
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 레지오넬라 검사 시장은 2024년에 2억 8,425만 달러로 평가되며, 예측 기간 동안 9.39%의 CAGR로 2030년에는 4억 8,715만 달러에 달할 것으로 예상됩니다.
레지오넬라 검사 세계 시장은 레지오넬라균, 특히 레지오넬라증을 유발하는 원인균인 Legionella pneumophila(레지오넬라 뉴모필라)의 검출 및 모니터링에 사용되는 진단 검사 및 서비스 시장을 의미합니다. 레지오넬라증은 심각한 폐렴으로 냉각탑, 온수 욕조, 배관 시스템 등에서 발생하는 오염된 물방울을 흡입함으로써 감염됩니다. 질병관리본부에 따르면 2018년 한 해 동안 약 10,000건의 레지오넬라증이 보고됐습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
2억 8,425만 달러
시장 규모 : 2030년
4억 8,715만 달러
CAGR : 2025-2030년
9.39%
급성장 부문
PCR 시장
최대 시장
아시아태평양
레지오넬라균은 온수 환경에서 번식하기 때문에 학교, 식당, 병원, 대규모 배관 시스템 등 물 저장에 의존하는 산업은 특히 레지오넬라균 오염에 취약합니다. 그 결과, 레지오넬라균 및 관련 감염증의 정확하고 시기적절한 진단에 대한 수요가 이들 산업 전반에 걸쳐 증가하고 있으며, 2022년 9월 아르헨티나 산 미겔 데 투쿠만에서 중증 폐렴이 발생하여 4명이 사망하고 11명이 중태에 빠지는 사건이 발생하였습니다. 이 집단 발병은 나중에 레지오넬라균, 특히 L.pneumophila균과 관련이 있는 것으로 밝혀졌습니다. 또한 2022년 6월, 뉴욕주 법무장관은 Verizon과 합의에 도달하여 Verizon이 뉴욕주 전역에서 레지오넬라증 확산을 방지하기 위해 신속하고 종합적인 조치를 취할 것을 확인했습니다.
주요 시장 촉진요인
검사 기술의 발전
주요 시장 과제
표준화된 검사 프로토콜의 부족
주요 시장 동향
신속 진단 검사
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 레지오넬라 검사 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
유형별(수질 검사, 체외진단 검사)
용도별(미생물 배양, 직접 형광 항체(DFA) 염색, PCR, 기타)
지역별
기업별(2024)
제품 시장 맵
유형별
최종 용도별
지역별
제6장 북미의 레지오넬라 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 레지오넬라 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
프랑스
이탈리아
스페인
제8장 아시아태평양의 레지오넬라 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
일본
인도
호주
한국
제9장 남미의 레지오넬라 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 레지오넬라 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
인수합병
제품 출시
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제14장 경쟁 구도
Abbott Laboratories
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
BIOMERIEUX SA
Eiken Chemical Co., Ltd
Hologic Inc.
Pro-Lab PLC
QIAGEN N.V.
F. Hoffmann-La Roche Ltd
Takara Bio Inc.
Thermo Fisher Scientific Inc.
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
Global Legionella Testing Market was valued at USD 284.25 million in 2024 and is expected to reach USD 487.15 million by 2030 with a CAGR of 9.39% during the forecast period. The Global Legionella Testing Market refers to the market for diagnostic tests and services used to detect and monitor Legionella bacteria, particularly the Legionella pneumophila species, responsible for causing Legionnaires' disease. Legionnaires' disease is a severe form of pneumonia that can be contracted through inhalation of contaminated water droplets, typically from sources like cooling towers, hot tubs, and plumbing systems. According to the Centers for Disease Control and Prevention, approximately 10,000 cases of Legionnaires' disease were reported in 2018.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 284.25 Million
Market Size 2030
USD 487.15 Million
CAGR 2025-2030
9.39%
Fastest Growing Segment
PCR
Largest Market
Asia Pacific
Legionella bacteria thrive in hot water conditions, making industries that rely on water storage, such as schools, restaurants, hospitals, and large plumbing systems, particularly susceptible to Legionella contamination. As a result, there is a growing demand across these industries for accurate and timely diagnosis of Legionella and related infections. In September 2022, an outbreak of severe pneumonia in San Miguel de Tucuman, Argentina, resulted in four deaths and 11 cases of severe illness. This outbreak was later linked to Legionella, specifically the bacterium L. pneumophila. Additionally, in June 2022, the New York Attorney General reached an agreement with Verizon to ensure the company takes swift and comprehensive action to prevent the spread of Legionnaires' disease throughout New York State.
Key Market Drivers
Advances in Testing Technologies
The Global Legionella Testing Market is experiencing substantial growth, and one of the key drivers behind this expansion is the continuous advancement of testing technologies. Legionella, a bacterium responsible for Legionnaires' disease, poses a significant public health risk. The need for rapid, sensitive, and accurate testing methods has driven innovation in the field.
Traditional methods of detecting Legionella bacteria, such as culture-based techniques, can be time-consuming and may not always yield accurate results. In contrast, modern molecular techniques, particularly Polymerase Chain Reaction (PCR), have revolutionized Legionella testing. PCR allows for the rapid and precise detection of Legionella DNA in water and environmental samples, significantly reducing the time required for diagnosis. The ability to provide quicker and more accurate results is a key factor driving the demand for Legionella testing services.
The sensitivity of testing methods is crucial when dealing with potentially harmful microorganisms like Legionella. Advances in testing technologies have led to the development of highly sensitive assays. These assays can detect even trace amounts of Legionella bacteria in various samples, including water systems, cooling towers, and air. Enhanced sensitivity ensures that potential sources of contamination are not overlooked, thereby improving the overall safety of water systems.
Automation in testing technologies has not only sped up the testing process but has also minimized the potential for human error. Automated platforms reduce the manual handling of samples, leading to greater consistency and reliability in test results. This feature is especially important in Legionella testing, where accuracy is critical for public health and safety.
Key Market Challenges
Lack of Standardized Testing Protocols
One of the primary challenges in the Legionella testing industry is the absence of standardized testing protocols. Different laboratories and testing facilities may use varying methods and equipment, leading to potential inconsistencies in results. Standardization is crucial to ensure that test results are accurate and can be reliably interpreted.
Key Market Trends
Rapid Diagnostic Tests
Rapid diagnostic tests are set to revolutionize the Legionella Testing Market. These tests offer quicker results, typically within hours, as opposed to the days required by traditional methods. Their speed and accuracy make them invaluable for timely decision-making in Legionella risk management. As demand for fast and reliable testing increases, rapid diagnostic tests will likely gain significant traction.
Key Market Players
Abbott Laboratories
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
BIOMERIEUX SA
Eiken Chemical Co., Ltd
Hologic Inc.
Pro-Lab PLC
QIAGEN N.V.
F. Hoffmann-La Roche Ltd
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Report Scope:
In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Legionella Testing Market, By Type:
Water testing
IVD testing
Legionella Testing Market, By End Use:
Microbial culture
Direct fluorescent antibody (DFA) stain
PCR
Others
Legionella Testing Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.
Available Customizations:
Global Legionella Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Legionella Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Water testing, IVD testing)
5.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Product Market Map
5.3.1. By Type
5.3.2. By End Use
5.3.3. By Region
6. North America Legionella Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Water testing, IVD testing)
6.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Legionella Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By End Use
6.3.2. Canada Legionella Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By End Use
6.3.3. Mexico Legionella Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End Use
7. Europe Legionella Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Water testing, IVD testing)
7.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Legionella Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End Use
7.3.2. United Kingdom Legionella Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End Use
7.3.3. France Legionella Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End Use
7.3.4. Italy Legionella Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End Use
7.3.5. Spain Legionella Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End Use
8. Asia-Pacific Legionella Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Water testing, IVD testing)
8.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Legionella Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End Use
8.3.2. Japan Legionella Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End Use
8.3.3. India Legionella Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End Use
8.3.4. Australia Legionella Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End Use
8.3.5. South Korea Legionella Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End Use
9. South America Legionella Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Water testing, IVD testing)
9.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Legionella Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End Use
9.3.2. Argentina Legionella Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End Use
9.3.3. Colombia Legionella Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End Use
10. Middle East and Africa Legionella Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Water testing, IVD testing)
10.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Legionella Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Legionella Testing Market Outlook
